Does innovativeness reduce startup survival rates?

Ari Hyytinen, Mika Pajarinen, Petri Rouvinen*

*Motsvarande författare för detta arbete

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

89 Citeringar (Scopus)


There are two competing hypotheses explaining how innovativeness influences the survival of startups: On the one hand, innovativeness is argued to foster survival-enhancing attributes (e.g., market power and cost efficiency) and capabilities (e.g., absorptive capacity). On the other hand, an innovative startup faces (and bears the associated risks of) liabilities of newness and smallness that exceed those of its non-innovative counterparts. The available empirical literature addressing this theoretical tension mostly supports the former hypothesis; we suggest that this finding is, in part, driven by the common practice of employing an ex post measure that already embodies a degree of success in innovativeness. We use an ex ante measure and find that a startup's innovativeness is negatively associated with its subsequent survival. We also find that entrepreneurs' greater appetite for risk magnifies this negative association. These findings imply that pursuing innovations is not necessarily associated with survival during the early stages of firm development and entails a more complicated start-up process.

Referentgranskad vetenskaplig tidskriftJournal of Business Venturing
Sidor (från-till)564-581
Antal sidor18
StatusPublicerad - 04.11.2014
MoE-publikationstypA1 Originalartikel i en vetenskaplig tidskrift


  • 511 Nationalekonomi

Fingeravtryck Fördjupa i forskningsämnen för ”Does innovativeness reduce startup survival rates?”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här